Cavorsi Robert 4
4 · Organogenesis Holdings Inc. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
Cavorsi Robert
Vice President, Strategy
Transactions
- Award
Class A Common Stock
2025-02-19+61,705→ 190,463 total - Award
Stock Option (Right to Buy)
2025-02-19+63,830→ 63,830 totalExercise: $3.53Exp: 2035-02-19→ Class A Common Stock (63,830 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2025.
- [F2]The option becomes exercisable in equal annual installments over four years beginning February 15, 2025.